Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells

American Journal of Pathology

Volumn 160, Issue 2, 2002, Pages 673-680

  Taraboletti, Giulia ^a   D'Ascenzo, Sandra ^b   Borsotti, Patrizia ^a   Giavazzi, Raffaella ^a   Pavan, Antonio ^b   Dolo, Vincenza ^b  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; GELATINASE A; GELATINASE B; MATRIGEL; MATRIX METALLOPROTEINASE 14; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOGOLD STAINING; MEMBRANE VESICLE; PRIORITY JOURNAL; PROTEIN DEGRADATION; WESTERN BLOTTING; ZYMOGRAPHY;

EID: 0036172425     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64887-0     Document Type: Article

References (34)

1. Shedding of plasma membrane fragments
2. Shedding from the cell surface of normal and cancer cells
3. Human breast carcinoma cells cultured in the presence of serum shed membrane vesicles rich in gelatinolytic activities
4. Urokinase plasminogen activator and gelatinases are associated with membrane vesicles shed by human HT-1080 fibrosarcoma cells
5. Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro
6. Angiogenesis in cancer and other diseases
7. Matrix metalloproteinases in angiogenesis: A moving target for therapeutic intervention
8. Matrix metalloproteinases
9. In vitro angiogenesis on the human amniotic membrane: Requirement for basic fibroblast growth factor-induced proteinases
10. Human dermal microvascular endothelial cells produce matrix metalloproteinases in response to angiogenic factors and migration
11. Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells
12. Vectorial secretion of extracellular matrix proteins, matrix-degrading proteinases, and tissue inhibitor of metalloproteinases by endothelial cells
13. Preclinical development of metalloproteasis inhibitors in cancer therapy
14. Development of matrix metalloproteinase inhibitors in cancer therapy
15. ECM and cell surface proteolysis: Regulating cellular ecology
16. Active and tissue inhibitor of matrix metalloproteinase-free gelatinase B accumulates within human microvascular endothelial vesicles
17. Posttranscriptional stimulation of endothelial cell matrix metalloproteinases 2 and 1 by endothelioma cells
18. Membrane vesicles shed into the extracellular medium by human breast carcinoma cells carry tumor-associated surface antigens
19. Selective localization of matrix metalloproteinase 9, beta1 integrins, and human lymphocyte antigen class I molecules on membrane vesicles shed by 8701-BC breast carcinoma cells
20. Inhibition of matrix metalloproteinases by over-expression of tissue inhibitor of metalloproteinase-2 inhibits the growth of experimental hemangiomas
21. Production and characterization of two monoclonal antibodies directed against the integrin β1 chain
22. The heparin binding 25 kDa fragment of thrombospondin-1 promotes angiogenesis and modulates gelatinase and TIMP-2 production in endothelial cells
23. Regulation of angiogenesis in vivo by ligation of integrin 5b1 with the central cell-binding domain of fibronectin
24. Interaction of endostatin with integrins implicated in angiogenesis
25. Modulation of vesicle shedding in 8701 BC human breast carcinoma cells
26. Vesicle-associated uPA system promotes invasion in prostate cancer cells
27. Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3
28. Vascular endothelial growth factor increases release of gelatinase A and decreases release of tissue inhibitor of metalloproteinases by microvascular endothelial cells in vitro
29. In vitro angiogenesis on the human amniotic membrane: Requirement for basic fibroblast growth factor-induce proteinases
30. Metastatic mouse melanoma cells release collagen-gelatin degrading metalloproteinases as components of shed membrane vesicles Biochim Biophys Acta
31. Arrest and metastasis of blood-born tumor cells are modified by fusion of plasma membrane vesicles from highly metastatic cells
32. Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro
33. Regulation of vascular growth and regression by matrix metalloproteinases in the rat aorta model of angiogenesis
34. Cell migration through extracellular matrix: Membranetype metalloproteinases make the way